NanJing Pharmaceutical Company Limited

600713

CNE000000KV1

Pharmaceuticals

End-of-day quote Shanghai S.E. Other stock markets 03:30:00 28/05/2024 am IST			5-day change	1st Jan Change
4.75 ^CNY	-1.25%		-3.26%	-1.86%

08:47am	Nanjing Pharmaceutical Issues 500 Million Yuan Ultra-Short-Term Bonds	MT
29/04	NanJing Pharmaceutical Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Sichuan Luyan Pharmaceutical Co., Ltd. agreed to acquire Sichuan Yatong Pharmaceutical Co., Ltd. from NanJing Pharmaceutical Company Limited for CNY 19.9 million.

November 09, 2021

Sichuan Luyan Pharmaceutical Co., Ltd. agreed to acquire Sichuan Yatong Pharmaceutical Co., Ltd. from NanJing Pharmaceutical Company Limited (SHSE:600713) for CNY 19.9 million on November 5, 2021. The transaction was approved by the Board of NanJing Pharmaceutical Company Limited.

Latest news about NanJing Pharmaceutical Company Limited

Nanjing Pharmaceutical Issues 500 Million Yuan Ultra-Short-Term Bonds	12:17pm	MT
NanJing Pharmaceutical Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2024	29/04	CI
NanJing Medical Plans to Issue Up to 6 Billion Yuan in Ultra Short-Term Bonds	08/04	MT
NanJing Pharmaceutical Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023	07/04	CI
NanJing Pharmaceutical Company Limited Reports Earnings Results for the Nine Months Ended September 30, 2023	30/23/30	CI
NanJing Pharmaceutical Company Limited(XSSC:600713) added to S&P Global BMI Index	18/23/18	CI
NanJing Pharmaceutical Company Limited Reports Earnings Results for the Half Year Ended June 30, 2023	30/23/30	CI
NanJing Pharmaceutical Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2023	28/23/28	CI
NanJing Pharmaceutical Company Limited Reports Earnings Results for the Full Year Ended December 31, 2022	30/23/30	CI
NanJing Pharmaceutical Company Limited entered into Framework Agreement to acquire 55% stake in Suzhou Tianqing Xingwei Pharmaceutical Co., Ltd., a 55% stake in Zhejiang Tianqing Zhongwei Pharmaceutical Co., Ltd., and a 100% of Lianyungang Chia Tai-Tianqing Pharmaceutical Co., Ltd.	21/22/21	CI
NanJing Pharmaceutical Company Limited Reports Earnings Results for the Nine Months Ended September 30, 2022	28/22/28	CI
NanJing Pharmaceutical Company Limited Reports Earnings Results for the Half Year Ended June 30, 2022	23/22/23	CI
NanJing Pharmaceutical Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2022	29/22/29	CI
NanJing Pharmaceutical Company Limited Reports Earnings Results for the Full Year Ended December 31, 2021	25/22/25	CI
NanJing Medical’s Controlling Shareholder Boosts Stake to 44.2% For $158 Million	21/22/21	MT
NanJing Pharmaceutical Company Limited announced that it has received CNY 997.999997 million in funding from Nanjing XinGong Investment Group Co., Ltd	14/22/14	CI
Sichuan Luyan Pharmaceutical Co., Ltd. agreed to acquire Sichuan Yatong Pharmaceutical Co., Ltd. from NanJing Pharmaceutical Company Limited for CNY 19.9 million.	09/21/09	CI
NanJing Pharmaceutical Company Limited Reports Earnings Results for the Nine Months Ended September 30, 2021	29/21/29	CI
NanJing Pharmaceutical Company Limited announced that it expects to receive CNY 999.999998 million in funding from Nanjing XinGong Investment Group Co., Ltd	10/21/10	CI
Nanjing Pharmaceutical Company Limited Reports Earnings Results for the Half Year Ended June 30, 2021	20/21/20	CI
Nanjing Pharmaceutical Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2021	27/21/27	CI
Nanjing Pharmaceutical Company Limited Reports Earnings Results for the Full Year Ended December 31, 2020	26/21/26	CI
Nanjing Pharmaceutical Company Limited Reports Earnings Results for the Half Year Ended June 30, 2020	21/20/21	CI
NanJing Pharmaceutical Company Limited Declares Distribution for 2019, Payable on June 24, 2020	16/20/16	CI
Nanjing Pharmaceutical Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2020	29/20/29	CI

Chart NanJing Pharmaceutical Company Limited

Duration

Period

Chart NanJing Pharmaceutical Company Limited

More charts

Company Profile

NanJing Pharmaceutical Company Limited is a China-based company principally engaged in the pharmaceutical distribution business. The Company's principal businesses include the pharmaceutical wholesale, pharmaceutical retail, pharmaceutical-Internet + business, as well as the pharmaceutical third-party logistics services. The Company mainly conducts its business in domestic market.

Sector

Pharmaceuticals

Calendar

31/05/2024 - Annual General Meeting

More about the company

Income Statement Evolution

More financial data

Sector Pharmaceuticals Wholesale

	1st Jan change	Capi.
NANJING PHARMACEUTICAL COMPANY LIMITED	-1.86%	870M
MCKESSON CORPORATION	+18.39%	72.89B
CARDINAL HEALTH, INC.	-6.23%	23.48B
SINOPHARM GROUP CO. LTD.	+4.65%	8.67B
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD	+9.32%	8.51B
HUADONG MEDICINE CO., LTD	-25.47%	7.71B
H. LUNDBECK A/S	+13.37%	5.21B
EBOS GROUP LIMITED	+1.58%	4.23B
JOINTOWN PHARMACEUTICAL GROUP CO., LTD	+5.71%	4.08B
GALENICA AG	+1.24%	3.99B